SCHEMBL24700422

SCHEMBL24700422

CC1CN(C(=O)OC(C)(C)C)C(C)(C)CC1N1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.39
▸ CTSK P43235 1/20 0.35
▸ EPHX1 P07099 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PREP P48147 2/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ GRIN2B Q13224 1/20 0.32
▸ GRIN2C Q14957 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NR1H2 P55055 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ RIN1 Q13671 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24700457 0.80 RORC (0.42) NR1H2
SCHEMBL24700458 0.78 STS (0.39) OPRK1NR1H2
SCHEMBL24700163 0.77 HPGD (0.43) HPGDCTSKEPHX1MEN1ALDH1A1
SCHEMBL16080216 0.76 NR1H2 (0.41) HPGDCTSKMEN1KMT2AEPHX2
SCHEMBL24700278 0.76 HPGD (0.42) HPGDCTSKEPHX1MEN1ALDH1A1
SCHEMBL31691884 0.74 HPGD (0.48) HPGDCTSKEPHX1MEN1ALDH1A1
SCHEMBL19947013 0.73 HPGD (0.55) HPGDEPHX1MEN1ALDH1A1MAPT
SCHEMBL20973202 0.73 CHRM2 (0.44) HPGDCTSKEPHX2GRIN2BGRIN2C
SCHEMBL21274860 0.73 CHRM2 (0.44) HPGDCTSKEPHX2GRIN2BGRIN2C
SCHEMBL28838859 0.72 HPGD (0.40) HPGDEPHX1MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220380314-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380314-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GBA2, CLN6 HPGD 213/4885CTSK 247/4885EPHX1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback